17962472

Source:http://linkedlifedata.com/resource/pubmed/id/17962472

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011209, umls-concept:C0021701, umls-concept:C0231491, umls-concept:C0301625, umls-concept:C0600518, umls-concept:C1510884, umls-concept:C2001569
pubmed:issue	11
pubmed:dateCreated	2007-10-26
pubmed:abstractText	To evaluate the angiogenic inhibitory effects of an alpha(v)beta(3)/alpha(v)beta(5) integrin antagonist, EMD478761, released from a polymeric implant in a chick chorioallantoic membrane (CAM) assay and laser-induced experimental choroidal neovascularization (CNV) in rats.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7703701
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Benzoxazines, http://linkedlifedata.com/resource/pubmed/chemical/Drug Implants, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Integrin alphaVbeta3, http://linkedlifedata.com/resource/pubmed/chemical/Integrins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vitronectin, http://linkedlifedata.com/resource/pubmed/chemical/integrin alphaVbeta5
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0146-0404
pubmed:author	pubmed-author:CsakyKarl GKG, pubmed-author:FuYingliY, pubmed-author:PonceM LourdesML, pubmed-author:ThillMichelleM, pubmed-author:WangNam SunNS, pubmed-author:YuanPengP
pubmed:issnType	Print
pubmed:volume	48
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5184-90
pubmed:meshHeading	pubmed-meshheading:17962472-Angiogenesis Inhibitors, pubmed-meshheading:17962472-Animals, pubmed-meshheading:17962472-Benzoxazines, pubmed-meshheading:17962472-Chick Embryo, pubmed-meshheading:17962472-Chorioallantoic Membrane, pubmed-meshheading:17962472-Choroidal Neovascularization, pubmed-meshheading:17962472-Chromatography, High Pressure Liquid, pubmed-meshheading:17962472-Disease Models, Animal, pubmed-meshheading:17962472-Drug Delivery Systems, pubmed-meshheading:17962472-Drug Implants, pubmed-meshheading:17962472-Fibroblast Growth Factor 2, pubmed-meshheading:17962472-Injections, pubmed-meshheading:17962472-Integrin alphaVbeta3, pubmed-meshheading:17962472-Integrins, pubmed-meshheading:17962472-Laser Therapy, pubmed-meshheading:17962472-Male, pubmed-meshheading:17962472-Neovascularization, Pathologic, pubmed-meshheading:17962472-Rats, pubmed-meshheading:17962472-Rats, Inbred BN, pubmed-meshheading:17962472-Receptors, Vitronectin, pubmed-meshheading:17962472-Vitreous Body
pubmed:year	2007
pubmed:articleTitle	Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
pubmed:affiliation	National Eye Institute, NIH, Bethesda, MD, USA.
pubmed:publicationType	Journal Article